Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
BNB treasury company plunges 77% after Nasdaq delisting notice
Related Posts
Winklevoss slams DCG’s Silbert — Not even SBF was ‘capable of such delusion’
In an open letter, Cameron Winklevoss slammed DCG’s Barry Silbert for allegedly playing the victim card while owing…
Vitalik Buterin: L2s are ‘cultural extensions’ of Ethereum
Buterin said Ethereum layer 2s have become “the ultimate playing field for action” from institutional profit-oriented groups and…
Yuga Labs co-founder addresses comeback rumors amid ongoing health break
Wylie Aronow said he’s been seeing a number of tweets this week asking when he’s planning to return…